Insulin Cancer Research Results

Insulin, Insulin: Click to Expand ⟱
Source:
Type:
Insulin, traditionally known for its role in regulating blood glucose levels, also exerts potent mitogenic (cell division–promoting) effects.

Insulin exerts its effects primarily through binding to the insulin receptor (IR), a receptor tyrosine kinase. Upon binding, the receptor undergoes autophosphorylation and activates several downstream signaling cascades, including:
-PI3K/Akt Pathway: Overactivation of this pathway is often observed in cancers.
-RAS/MAPK Pathway: aberrant activation can lead to tumorigenesis.

IR-A: Often predominates in fetal tissues and some cancer cells. It has a higher affinity for insulin-like growth factors (IGFs) and is more mitogenic.
IR-B: More involved in metabolic regulation.

Studies have shown that many cancers (such as breast, colon, and lung cancers) preferentially overexpress the IR-A isoform.


Scientific Papers found: Click to Expand⟱
2761- BetA,    Betulinic acid increases lifespan and stress resistance via insulin/IGF-1 signaling pathway in Caenorhabditis elegans
- in-vivo, Nor, NA
Insulin↓, IGF-1↓, *SOD↑, *Catalase↑, *GSH↑, *MDA↓, *antiOx?,
5780- CRMs,  HCAs,  RES,  Sper,  ASA  Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
- Review, Var, NA
*OS↑, *AntiAge↑, *cardioP↑, *neuroP↑, AntiCan↑, *TNF-α↓, *Weight↓, *BP↓, *Inflam↓, *Insulin↓, *ROS↓, *AMPK↑, *mTOR↓, *SIRT1↑, CRM↑,
1863- dietFMD,  Chemo,    Effect of fasting on cancer: A narrative review of scientific evidence
- Review, Var, NA
eff↑, ChemoSideEff↓, ChemoSen↑, Insulin↓, HDAC↓, IGF-1↓, STAT5↓, BG↓, MAPK↓, HO-1↓, ATG3↑, Beclin-1↑, p62↑, SIRT1↑, LAMP2↑, OXPHOS↑, ROS↑, P53↑, DNAdam↑, TumCD↑, ATP↑, Treg lymp↓, M2 MC↓, CD8+↑, Glycolysis↓, GutMicro↑, GutMicro↑, Warburg↓, Dose↝,
1853- dietFMD,    Impact of Fasting on Patients With Cancer: An Integrative Review
- Review, Var, NA
*toxicity∅, QoL∅, eff↑, eff↝, ChemoSideEff↓, TumCG↓, Dose↑, toxicity↝, eff↑, IGF-1↑, *OXPHOS↑, BG↓, Insulin↓, RadioS↑,
1855- dietFMD,    Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study
- Trial, NA, NA
ChemoSideEff↓, QoL↑, IGF-1↓, Insulin↓,
2269- dietMet,    Mechanisms of Increased In Vivo Insulin Sensitivity by Dietary Methionine Restriction in Mice
- in-vivo, Nor, NA
*adiP↑, *FGF↑, *Insulin↓, *glucose↓, *Akt↑, *GSH↓, *PTEN↓, *FGF21↑, *PIP3↑,
2263- dietMet,    Methionine Restriction and Cancer Biology
- Review, Var, NA
AntiCan↑, TumCP↓, TumCG↓, selectivity↑, ChemoSen↓, RadioS↑, Insulin↓, *GlucoseCon↑, *ROS↓, *antiOx↑, *GSH↑, GSH↑, eff↑, polyA↓, TS↓, Raf↓, Akt↓, Casp9↑, Bak↑, P21↑, p27↑, Insulin↓, IGF-1↓,
2265- dietMet,    Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase
- in-vivo, Nor, NA
*SCD1↓, *Weight↓, *Insulin↓, *IGF-1↓, *adiP↑, *eff↓,
5066- dietSTF,    Intermittent and Periodic Fasting, Hormones, and Cancer Prevention
- Review, Var, NA
IGF-1↓, OS↑, AntiAge↑, glucose↓, Insulin↓,
5069- dietSTF,    The Role of Intermittent Fasting in the Activation of Autophagy Processes in the Context of Cancer Diseases
- Review, Var, NA
Risk↓, ChemoSen↑, RadioS↑, *Dose↝, *Dose↝, *Dose↝, *LDL↓, *CRP↓, *TNF-α↓, TumAuto↓, GLUT1↓, GLUT2↓, glucose↓, IGF-1↓, Insulin↓, mTOR↓, mTORC1↓, AMPK↑, Warburg↓, OXPHOS↑, ROS↑, DNAdam↑, JAK1↓, STAT↓, TumCP↓, QoL↑,
3708- dietSTF,    Fasting as a Therapy in Neurological Disease
*PGC-1α↑, *AMPK↑, *adiP↑, *glucose↓, *Insulin↓, *mTOR↓, *IL6↓, *TNF-α↓, *cognitive↑, *Inflam↓, *eff↑, *neuroP↑, ChemoSen↑, eff↓, chemoP↑, *eff↑,
5064- Ex,    Insulin,_Igfs.996.aspx">Effect Of Exercise Intervention On Insulin, Igfs And Igfbps In Cancer Patients
- Review, Var, NA
IGF-1↓, IGF-2↓, Insulin↓,
5235- Ex,    Effect of Low-Intensity Aerobic Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Proteins in Healthy Men
- Trial, Nor, NA
Insulin↓, IGF-1↓, IGFBP1↑, eff↑,
5795- MET,    Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
- Review, AD, NA - Review, Park, NA - Review, Diabetic, NA
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
2248- MF,    Magnetic fields modulate metabolism and gut microbiome in correlation with Pgc-1α expression: Follow-up to an in vitro magnetic mitohormetic study
- in-vivo, Nor, NA
*PGC-1α↑, *GutMicro↑, *FAO↓, *Insulin↓,
2333- RES,    Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells
- in-vitro, Nor, NA
*glucose↓, *Insulin↓, *IGFR↓, *IGF-1↓, *LDHA↑, *HK2↑, *PKM2↑, *Glycolysis↝, *SIRT2↑,

Showing Research Papers: 1 to 16 of 16

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 16

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

GSH↑, 1,   HO-1↓, 1,   OXPHOS↑, 2,   ROS↑, 3,  

Mitochondria & Bioenergetics

ATP↑, 1,   Insulin↓, 10,   MMP↓, 1,   Raf↓, 1,  

Core Metabolism/Glycolysis

AMPK↑, 1,   CRM↑, 1,   glucose↓, 2,   GLUT2↓, 1,   Glycolysis↓, 1,   polyA↓, 1,   SIRT1↑, 1,   TS↓, 1,   Warburg↓, 2,  

Cell Death

Akt↓, 1,   Apoptosis↑, 1,   Bak↑, 1,   Casp↑, 1,   Casp9↑, 1,   MAPK↓, 1,   p27↓, 1,   p27↑, 1,   TumCD↑, 1,  

Transcription & Epigenetics

pRB↓, 1,  

Autophagy & Lysosomes

ATG3↑, 1,   Beclin-1↑, 1,   LAMP2↑, 1,   p62↑, 1,   TumAuto↓, 1,  

DNA Damage & Repair

DNAdam↑, 2,   P53↑, 1,  

Cell Cycle & Senescence

cycD1/CCND1↓, 1,   P21↑, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State

HDAC↓, 1,   IGF-1↓, 8,   IGF-1↑, 1,   IGF-2↓, 1,   IGFBP1↑, 1,   mTOR↓, 2,   mTORC1↓, 1,   STAT↓, 1,   STAT5↓, 1,   TumCG↓, 2,  

Migration

Treg lymp↓, 1,   TumCP↓, 3,  

Barriers & Transport

GLUT1↓, 1,  

Immune & Inflammatory Signaling

JAK1↓, 1,   M2 MC↓, 1,  

Drug Metabolism & Resistance

ChemoSen↓, 1,   ChemoSen↑, 4,   Dose↑, 1,   Dose↝, 1,   eff↓, 1,   eff↑, 5,   eff↝, 1,   RadioS↑, 3,   selectivity↑, 1,  

Clinical Biomarkers

BG↓, 2,   GutMicro↑, 2,  

Functional Outcomes

AntiAge↑, 1,   AntiCan↑, 3,   chemoP↑, 1,   ChemoSideEff↓, 3,   OS↑, 1,   QoL↑, 2,   QoL∅, 1,   Risk↓, 2,   toxicity↝, 1,  

Infection & Microbiome

CD8+↑, 1,  
Total Targets: 73

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx?, 1,   antiOx↑, 1,   Catalase↑, 1,   GSH↓, 1,   GSH↑, 2,   MDA↓, 1,   OXPHOS↑, 1,   ROS↓, 3,   SOD↑, 1,  

Mitochondria & Bioenergetics

Insulin↓, 7,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis

adiP↑, 3,   AMPK↑, 3,   CRM↑, 1,   FAO↓, 1,   FGF21↑, 1,   glucose↓, 4,   GlucoseCon↑, 1,   glyC↓, 1,   Glycolysis↝, 1,   HK2↑, 1,   LDHA↑, 1,   LDL↓, 1,   PIP3↑, 1,   PKM2↑, 1,   SCD1↓, 1,   SIRT1↑, 1,   SIRT2↑, 1,  

Cell Death

Akt↑, 1,  

Proliferation, Differentiation & Cell State

FGF↑, 1,   IGF-1↓, 2,   IGFR↓, 1,   mTOR↓, 2,   PTEN↓, 1,  

Immune & Inflammatory Signaling

CRP↓, 1,   IL6↓, 1,   Inflam↓, 2,   TNF-α↓, 3,  

Protein Aggregation

AGEs↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   Dose↝, 3,   eff↓, 1,   eff↑, 2,   Half-Life↝, 1,  

Clinical Biomarkers

BP↓, 1,   CRP↓, 1,   GutMicro↑, 1,   IL6↓, 1,  

Functional Outcomes

AntiAge↑, 1,   AntiDiabetic↑, 1,   cardioP↑, 2,   cognitive↑, 1,   hepatoP↑, 1,   neuroP↑, 3,   OS↑, 1,   toxicity↝, 1,   toxicity∅, 1,   Weight↓, 2,  
Total Targets: 58

Scientific Paper Hit Count for: Insulin, Insulin
3 diet FMD Fasting Mimicking Diet
3 diet Methionine-Restricted Diet
3 diet Short Term Fasting
2 Resveratrol
2 Exercise
1 Betulinic acid
1 Calorie Restriction Mimetics
1 Hydroxycinnamic-acid
1 Spermidine
1 Aspirin -acetylsalicylic acid
1 Chemotherapy
1 Metformin
1 Magnetic Fields
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1190  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page